Top
image credit: Pexels

How to get acquisition ready – a seller’s guide to merger and acquisition in pharma

December 28, 2022

In pharma, multi-billion-dollar deals dominate M&A headlines, but most deals are far shorter of this range and generally lie between $10-$500 million. Since the first wave of consolidation started in 1988, there has been a significant concentration of the pharma industry. In the last 15 years, there has been a noticeable shift towards many prominent players effectively outsourcing innovation to start-ups due to the increasing cost of R&D. In 2018, over 60% of all new molecular entities came from smaller biopharma firms, compared with just over 30% in 2009.

Read More on Pharmaphorum